peptídeo ghk-cu SUPER-GHK-Cu-5% – Unic Pharma Peptideo Bionexis GHK-Cu 50MG |

Epithalon Strength: 50 mg Higher-volume peptide option for advanced treatment planning and individualized protocols

PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165

Experimental data indicate that GHK-Cu can influence collagen and glycosaminoglycan synthesis, modulate proteoglycan and chondroitin sulfate turnover, and recruit fibroblasts, immune cells, and endothelial cells to sites of tissue injury

Most commercial formulations come pre-mixed in spray bottles designed for direct scalp application